Menu
Back to Journals » Infection and Drug Resistance » Call For Papers
Infection and Drug Resistance
ISSN: 1178-6973
The following Article Collection/ Thematic Series is currently open for submissions:
Antimicrobial Stewardship and Infection Control: A Global Perspective
Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "Antimicrobial Stewardship and Infection Control: A Global Perspective", organized by Guest Advisor Dr. Anucha Apisarnthanarak in Infection and Drug Resistance.
Antimicrobial resistance occurs commonly in public and in patient settings and is a major concern in a global scale. Inappropriate use and poor infection prevention are undeniable causes of antimicrobial resistance. Strategies to reduce antimicrobial resistance and effective control measures are needed. This article collection will address the epidemiology of, and innovative strategies to control for, antimicrobial resistance in a global perspective.
All articles pertaining to antimicrobial stewardship and/or infection control to limit transmission of antimicrobial resistance will be considered for publication. The scope of this article collection will also include laboratory stewardship, antimicrobial stewardship, interventions using Infection Control (IC) together with antimicrobial stewardship to curb multi-drug resistant (MDR) pathogens, novel stewardship strategy, novel IC strategies to reduce MDR, antimicrobial stewardship in resource-limited settings, etc. Articles pertaining to antimicrobial stewardship and control strategies in the community and public, antibiotic prescribing behaviors, as well as epidemiology of multi-drug resistant organisms are also welcome.
Guest advisor:
Dr. Anucha Apisarnthanarak is current the Professor and Chief of Infectious Diseases Division at Thammasat University Hospital. He also serves as an Adjunct Visiting Professor at Division of Infectious Diseases, Washington University School of Medicine, USA. Dr. Apisarnthanarak’s research focus included infection prevention in resource-limited setting, infection control to prevent multi-drug resistant microorganisms as well as outbreak investigations. He published more than 250 peer-review articles and more than 20 peer-review book chapters. He has been a key committee member of many national and international societies including Thai National Nosocomial Infection Group, Society of Healthcare Epidemiology of America, and Asia Pacific Society of Infection Control.
All manuscripts submitted to this Article Collection will undergo desk assessment and peer-review as part of our standard editorial process. Please review the journal Aims and Scope and author submission instructions prior to submitting a manuscript.
The deadline for submissions is 1 May 2024.
Please submit your manuscript on our website, quoting the promo code MKIRN to indicate that your submission is for consideration in this Article Collection.
Call For Papers
Editor-in-Chief: Professor Suresh Antony
To see where Infection and Drug Resistance is indexed online view the Journal Metrics.
What is the advantage to you of publishing in Infection and Drug Resistance?
- It is an open access journal which means that your paper is available to anyone in the world to download for free directly from the Dove website.
- Although Infection and Drug Resistance receives many papers, unlike most traditional journals, your paper will not be rejected due to lack of space. We are an electronic journal and there are no limits on the number or size of the papers we can publish.
- The time from submission to a decision being made on a paper can, in many journals, take some months and this is very frustrating for authors. Infection and Drug Resistance has a quicker turnaround time than this. Generally peer review is complete within 3-4 weeks and the editor’s decision within 2-14 days of this. It is therefore very rare to have to wait more than 6 weeks for first editorial decision.
- Many authors have found that our peer reviewer’s comments substantially add to their final papers.
To recover our editorial and production costs and continue to provide our content at no cost to readers we charge authors or their institution an article publishing charge.
PubMed Central
Infection and Drug Resistance is indexed on PubMed Central (title abbreviation: Infect Drug Resist). All published papers in this journal are submitted to PubMed for indexing straight away.
Become a Favored Author and receive real benefits
If you haven't already joined the Dove Press Favored Author Program I would encourage you to do so. Why? To receive real benefits like fast-tracking and a personal co-ordinator for your paper, as well as a discount on the publication processing fee.
Click here to go through to the Favored Author signup page.
Yours sincerely
Professor Suresh Antony
Editor-in-Chief
Infection and Drug Resistance
Email: Editor-in-Chief